Skip to main content
Premium Trial:

Request an Annual Quote

PE Biosystems Changes Name Back to Applied Biosystems

Premium

PE Biosystems will once again be known as Applied Biosystems.  The maker of the high-speed DNA sequencers that catalyzed the public-private human genome sequencing race was called Applied Biosystems before Perkin-Elmer. (Now PE) acquired it in 1993.

Formal stockholder approval of the name change is expected at its annual meeting in October.

The instrument developer, based in Foster City, Calif., is the sister company of Celera.  Both are operating groups of parent company PE Corp.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.